Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caldolor for Remifentanil-induced Postoperative Hyperalgesia
NCT02243254Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ibuprofen in opioid-induced hyperalgesia (OIH) and postoperative pain (4 arms), sponsored by Seoul National University Hospital. Primary endpoint: Cumulative morphine consumption at 48 hours. Started Jul 2014; status: completed.
02
Drugs
ibuprofen
03
Conditions
opioid-induced hyperalgesia (OIH)postoperative pain
Beyond the preview
Go deeper on NCT02243254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243254.